Show notes
In this episode of Derms and Conditions, Dr James Q Del Rosso is joined by Dr April Armstrong, Chair of Dermatology at UCLA, for a thorough discussion of oral therapies for plaque psoriasis—what’s new, what still works, and how to choose the right treatment for the right patient.They kick off with a practical discussion on older systemic options like methotrexate andcyclosporine, including when these tried-and-true agents still have a place in modern practice.From there, Dr Armstrong walks through the evolving role of apremilast, particularly in hard-to-treat variants like palmoplantar pustulosis and in patients with milder disease who prefer oraloptions. The pair then take listeners through the clinical data behind deucravacitinib, a selectiveTYK2 inhibitor, highlighting its strong efficacy, minimal lab monitoring, and newly released five-year safety results.The conversation also covers real-world patient selection, payer considerations, and howclinicians can use guidelines to support access to newer therapies. Whether you’re looking torefine your psoriasis treatment strategy or better counsel patients on long-term safety, thisepisode delivers practical pearls you can use in clinic tomorrow.



